AI assistant
PLUS THERAPEUTICS, INC. — Director's Dealing 2023
Dec 15, 2023
34301_dirs_2023-12-15_418e7bca-94c9-4bfa-b158-c0e0d150ca01.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2023-11-20
Reporting Person: HEDRICK MARC H (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-11-20 | Common Stock | S | 2068 | $1.9597 | Disposed | 170 | Direct |
Footnotes
F1: The transactions reflect inadvertent trades made by the reporting person's custodian without authorization.
F2: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices of $1.9601 or $1.9768 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.